Ping An Healthcare and Technology Company (1833) Stock Forecast & Price Target

Compare

16 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1833 Analyst Ratings

Hold

4 Buy

2 Hold

2 Sell

Based on 8 analysts giving stock ratings to

Ping

An Healthcare and Technology Company

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1833 Stock 12 Month Forecast

Average Price Target

HK$16.35

▲(14.33% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Ping An Healthcare and Technology Company in the last 3 months. The average price target is HK$16.35 with a high forecast of HK$21.00 and a low forecast of HK$5.90. The average price target represents a 14.33% change from the last price of HK$14.30.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"HK$3","12":"HK$12","21":"HK$21","7.5":"HK$7.5","16.5":"HK$16.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20.99999999748,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$21.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.34877384,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$16.35</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.899999999292,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$5.90</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,7.5,12,16.5,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.74,14.298461538267693,14.856923076535384,15.415384614803077,15.97384615307077,16.53230769133846,17.090769229606153,17.649230767873846,18.20769230614154,18.76615384440923,19.324615382676924,19.883076920944617,20.441538459212307,{"y":20.99999999748,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.74,13.94067491076923,14.141349821538462,14.342024732307692,14.542699643076924,14.743374553846154,14.944049464615384,15.144724375384616,15.345399286153846,15.546074196923076,15.746749107692308,15.947424018461538,16.14809892923077,{"y":16.34877384,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.74,13.136923076868616,12.533846153737231,11.930769230605847,11.32769230747446,10.724615384343078,10.121538461211692,9.518461538080308,8.915384614948923,8.312307691817539,7.7092307686861545,7.106153845554769,6.503076922423385,{"y":5.899999999292,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.085,"date":1709251200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4.085,"date":1711929600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.028,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.16,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.12,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.9,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.1,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.52,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.98,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.77,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":12,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.31,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.74,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetHK$21.00

Average Price TargetHK$16.35

Lowest Price TargetHK$5.90

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

China Renaissance

Not Ranked

China Renaissance

HK$19.29

Buy

34.90%

Upside

Reiterated

11/19/25

China Renaissance Keeps Their Buy Rating on Ping An Healthcare and Technology Company (PANHF)

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

HK$21

Buy

46.85%

Upside

Reiterated

11/06/25

Isla Carelynx

TR | OpenAI - 4o

HK$16.5

Hold

15.38%

Upside

Reiterated

10/29/25

AI Generated ArticleAI Generated Article

Unknown Analyst

UBS

Not Ranked

UBS

HK$16.5

Hold

15.38%

Upside

Reiterated

10/28/25

Unknown Analyst

SPDB

Not Ranked

SPDB

HK$14

Sell

-2.10%

Downside

Reiterated

10/28/25

Unknown Analyst

UOB Kay Hian

Not Ranked

UOB Kay Hian

HK$20

Buy

39.86%

Upside

Reiterated

10/24/25

Unknown Analyst

Citi

Not Ranked

Citi

HK$20→HK$18

Buy

25.87%

Upside

Reiterated

10/24/25

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

HK$16.3

Hold

13.99%

Upside

Reiterated

10/23/25

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

HK$16.3

Hold

13.99%

Upside

Reiterated

10/07/25

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

HK$21

Buy

46.85%

Upside

Reiterated

08/26/25

Chris Lui

Jefferies

HK$4.8→HK$5.9

Sell

-58.74%

Downside

Reiterated

08/24/25

Jefferies Sticks to Their Sell Rating for Ping An Healthcare and Technology Company (PANHF)

Unknown Analyst

Citi

Not Ranked

Citi

HK$20

Buy

39.86%

Upside

Reiterated

08/21/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$17.2

Buy

20.28%

Upside

Reiterated

08/20/25

Unknown Analyst

CLSA

Not Ranked

CLSA

HK$20

Buy

39.86%

Upside

Reiterated

08/20/25

Unknown Analyst

GF Securities

Not Ranked

GF Securities

HK$9.42

Buy

-34.13%

Downside

Reiterated

03/19/25

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

China Renaissance

Not Ranked

China Renaissance

HK$19.29

Buy

34.90%

Upside

Reiterated

11/19/25

China Renaissance Keeps Their Buy Rating on Ping An Healthcare and Technology Company (PANHF)

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

HK$21

Buy

46.85%

Upside

Reiterated

11/06/25

Isla Carelynx

TR | OpenAI - 4o

HK$16.5

Hold

15.38%

Upside

Reiterated

10/29/25

AI Generated ArticleAI Generated Article

Unknown Analyst

UBS

Not Ranked

UBS

HK$16.5

Hold

15.38%

Upside

Reiterated

10/28/25

Unknown Analyst

SPDB

Not Ranked

SPDB

HK$14

Sell

-2.10%

Downside

Reiterated

10/28/25

Unknown Analyst

UOB Kay Hian

Not Ranked

UOB Kay Hian

HK$20

Buy

39.86%

Upside

Reiterated

10/24/25

Unknown Analyst

Citi

Not Ranked

Citi

HK$20→HK$18

Buy

25.87%

Upside

Reiterated

10/24/25

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

HK$16.3

Hold

13.99%

Upside

Reiterated

10/23/25

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

HK$16.3

Hold

13.99%

Upside

Reiterated

10/07/25

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

HK$21

Buy

46.85%

Upside

Reiterated

08/26/25

Chris Lui

Jefferies

HK$4.8→HK$5.9

Sell

-58.74%

Downside

Reiterated

08/24/25

Jefferies Sticks to Their Sell Rating for Ping An Healthcare and Technology Company (PANHF)

Unknown Analyst

Citi

Not Ranked

Citi

HK$20

Buy

39.86%

Upside

Reiterated

08/21/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

HK$17.2

Buy

20.28%

Upside

Reiterated

08/20/25

Unknown Analyst

CLSA

Not Ranked

CLSA

HK$20

Buy

39.86%

Upside

Reiterated

08/20/25

Unknown Analyst

GF Securities

Not Ranked

GF Securities

HK$9.42

Buy

-34.13%

Downside

Reiterated

03/19/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ping An Healthcare and Technology Company

1 Month

xxx

Success Rate

2/3 ratings generated profit

Average Return

+0.70%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +0.70% per trade.

3 Months

xxx

Success Rate

3/3 ratings generated profit

Average Return

+24.93%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +24.93% per trade.

1 Year

Chris LuiJefferies

Success Rate

3/3 ratings generated profit

Average Return

+449.03%

reiterated a sell rating 3 months ago

Copying Chris Lui's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +449.03% per trade.

2 Years

xxx

Success Rate

3/3 ratings generated profit

Average Return

+537.30%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +537.30% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1833 Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1833 has received 8 Buy Ratings, 4 Hold Ratings, and 1 Sell Ratings. 1833 average Analyst price target in the past 3 months is 16.35.

Each month's total comprises the sum of three months' worth of ratings.

1833 Financial Forecast

1833 Earnings Forecast

Currently, no earnings data available.

1833 Sales Forecast

Currently, no sales data available.

1833 Stock Forecast FAQ

What is HK:1833’s average 12-month price target, according to analysts?

Based on analyst ratings, Ping An Healthcare and Technology Company Limited’s 12-month average price target is 16.35.

What is HK:1833’s upside potential, based on the analysts’ average price target?

Ping An Healthcare and Technology Company Limited has 14.33% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Ping An Healthcare and Technology Company Limited a Buy, Sell or Hold?

Ping An Healthcare and Technology Company Limited has a consensus rating of Hold, which is based on 4 buy ratings, 2 hold ratings and 2 sell ratings.

What is Ping An Healthcare and Technology Company Limited’s share price target?

The average share price target for Ping An Healthcare and Technology Company Limited is 16.35. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$21.00 ,and the lowest forecast is HK$5.90. The average share price target represents 14.33% Increase from the current price of HK$14.3.

What do analysts say about Ping An Healthcare and Technology Company Limited?

Ping An Healthcare and Technology Company Limited’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of Ping An Healthcare and Technology Company Limited?

To buy shares of HK:1833, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Ping An Healthcare and Technology Company (1833) Stock Forecast & Price Target

1833 Analyst Ratings

1833 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Ping An Healthcare and Technology Company

1833 Analyst Recommendation Trends

1833 Financial Forecast

1833 Earnings Forecast

1833 Sales Forecast

1833 Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts